Skip to content

AbbVie Inc.

ABBV

CIK 0001551152

← back to feed
Revenue (TTM)
$31.44B
+8.6% YoY Q1 Apr 2026
Net Income (TTM)
$3.11B
+8,354.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
$1.73
+5,200.0% YoY Q1 Apr 2026
Gross Margin
38.4%
Q1 Apr 2026
Operating Margin
46.2%
Q1 Apr 2026
Net Margin
9.9%
Q1 Apr 2026
Free Cash Flow (TTM)
$12.83B
Q1 Apr 2026
Cash
$9.39B
Q1 Apr 2026
Total Debt
$64.5B
Q1 Apr 2026
Shares Outstanding
1.77B sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings